Memorial Sloan Kettering Researchers Identify Early Tumor Microenvironment Dynamics in Lung Cancer
Researchers at Memorial Sloan Kettering Cancer Center have made significant strides in understanding the early stages of lung cancer development. Their study, published in Nature, reveals how mutant lung epithelial cells with KRAS mutations manipulate their surroundings to create a tumor-friendly microenvironment. These cells recruit and alter normal cells, including fibroblasts and immune cells, to support tumor growth. The study highlights the role of the tumor microenvironment, emphasizing the interactions between malignant and non-malignant cells as crucial in cancer progression. Using advanced lineage-tracing techniques in mouse models, the researchers tracked the behavior of KRAS-mutant cells, discovering that these cells enter an aberrant regenerative state, similar to normal lung stem cells during tissue repair. This state leads to the secretion of amphiregulin (AREG), which activates fibroblasts to form a fibrotic niche that supports tumor growth and suppresses immune responses. 
